0

Brain Biogenic Amines in Diabetes

Brain Biogenic Amines and Protein Kinases in Experimental Diabetes

Erschienen am 10.08.2014, 1. Auflage 2014
61,90 €
(inkl. MwSt.)

Lieferbar innerhalb 1 - 2 Wochen

In den Warenkorb
Bibliografische Daten
ISBN/EAN: 9783659563782
Sprache: Englisch
Umfang: 148 S.
Format (T/L/B): 0.9 x 22 x 15 cm
Einband: kartoniertes Buch

Beschreibung

Catecholamines and Indoleamines level were studied in Striatum, hippocampus, hypothalamus, Midbrain, Pons Medulla, Cerebellum and Cerebral Cortex under alloxan-diabetic, glucose-induced-hyperglycaemic, NH4Cl or Sodium Acetoacetate-induced acidotic and insulin-treatment to all these animals, after 7, 30 and 60 days. We also studied the roles of Protein Kinases such as PKC-, p38MAPK, CaM Kinase II and PKAII as well as S-100/SERT on the regulation of brain biogenic amines (both In vivo and In vitro) under similar conditions. We found that Dopamine, Epinephrine, Norepinephrine, 5-HT and 5-HIAA were altered under experimental diabetes, hyperglycemic as well as acidotic conditions in some specific areas of brain which is not identical with each other suggesting that the changes observed are not generalized effect rather it is specific to the treatment regimen. The catecholamines and p38MAPK level were increased simultaneously while indoleamines were regulated by PKC-, CaM Kinase II, PKAII and S100B/SERT under diabetic, hyperglycemic and acidotic conditions in some specific areas of brain. Insulin treatments reversed all these changes to normal level.

Produktsicherheitsverordnung

Hersteller:
BoD - Books on Demand
info@bod.de
In de Tarpen 42
DE 22848 Norderstedt

Autorenportrait

Dr. Ramakrishnan has obtained his PhD degree in 1995. He worked on diabetes, cancer, gallstone and brain edema related researches in India, Japan and USA for two decades. He authored several articles and published in peer-reviewed international journals and is an active member of several scientific societies and research teams.